Scientists working to develop new therapies and treatments for heart failure patients have discovered three proteins that can be injected immediately after a heart attack, which have the potential to preserve heart function following an attack.
The latest research on plants brought to you by Newswise.
New research from the Smidt Heart Institute at Cedars-Sinai demonstrated that women—when height is accounted for—have a 50% higher risk of developing the abnormal heart rhythm disturbance when compared to men.
Among people older than age 65 who were assessed using a short physical function test, having lower physical function was independently associated with a greater risk of developing heart attack, heart failure and stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
In Biophysics Reviews, researchers explore how human tissue models can be used to examine the impact of heart attacks and treatment of the fibrotic tissue outside the body, improving treatment and diagnosis. They use organoids, 3D organlike multicellular models derived from stem cells, to mimic natural development, structural organization, regeneration, and disease progression. Meanwhile, microfluidic devices control cell placement and fluid flow to act like the heart on a chip, while bioprinting allows cardiac tissue to be built up layer by layer.
In the Journal of Applied Physics, researchers develop a method to identify aortic valve dysfunction using complex network analysis that is accurate, simple to use, and low-cost. They used heart sound data to create a complex network of connected points, which was split into sections, and each part was represented with a node. If the sound in two portions was similar, a line was drawn between them. In a healthy heart, the graph showed two distinct clusters of points, with many nodes unconnected. A heart with aortic stenosis contained many more correlations and edges.
During National Atrial Fibrillation (AFib) Awareness Month and Aortic Disease Awareness Week, Smidt Heart Institute cardiologists and surgeons are available for interviews with journalists working on stories about these common heart conditions.
A six-year analysis of more than 94,000 adults in the U.K. Biobank with no history of heart failure at enrollment has found that engaging in moderate or vigorous physical activity may lower the risk of developing heart failure, according to new research published today in the American Heart Association’s flagship journal Circulation.
A new type of extravascular implantable cardioverter-defibrillator (ICD) using a lead (thin wire) placed behind the sternum met safety and effectiveness goals for participants in a premarket global clinical study. The device effectively terminated acute and chronic life-threatening ventricular arrhythmias. The findings were presented during a late-breaking session at the European Society of Cardiology Congress and were simultaneously published in The New England Journal of Medicine.
All too often, patients go to the ER complaining of unexplained chest pain. After a battery of tests show no evidence of blocked heart arteries, the patients are sent home. Then, they return to the ER with the same symptoms. Until now. MedStar Heart & Vascular Institute is one of the few programs in the nation to have the innovative tool to find the culprit: coronary microvascular dysfunction, or CMD, a condition in which the heart’s tiniest arteries don’t dilate properly.
In a first-of-its-kind randomized clinical trial led by researchers at the Smidt Heart Institute and the Division of Artificial Intelligence in Medicine at Cedars-Sinai, artificial intelligence (AI) proved more successful in assessing and diagnosing cardiac function when compared to echocardiogram assessments made by sonographers.
Mount Sinai researchers develop new risk stratification tool to optimize patient care and outcomes after TAVR
An analysis in nearly 2.3 million Europeans has found detrimental associations between cold weather and deaths from heart disease, particularly in poor neighbourhoods.
A three-drug medication known as a “polypill,” developed by the Spanish National Center for Cardiovascular Research (CNIC) and Ferrer, is effective in preventing secondary adverse cardiovascular events in people who have previously had a heart attack, reducing cardiovascular mortality by 33 percent in this patient population.
High blood pressure in pregnancy is increasing and a leading cause of maternal death
More than one in eight children (12%) receiving implanted cardiovascular defibrillators (ICDs) for heart rhythm problems exhibit signs of post-traumatic stress disorder (PTSD), according to a new report in Heart Rhythm, the official journal of the Heart Rhythm Society, the Cardiac Electrophysiology Society, and the Pediatric & Congenital Electrophysiology Society, published by Elsevier.
Researchers at University Hospitals, with support from an American Heart Association® grant, will work to better understand how to successfully treat Black women diagnosed with depression who are also at risk for high blood pressure.
The Cardiovascular Research Foundation (CRF) and Fogarty Innovation announced today that the program is now available for the TCT MedTech Innovation Forum. The summit will be held on the first day of TCT, the annual scientific symposium of CRF, on Friday, September 16. TCT will take place September 16-19, 2022, in Boston, Massachusetts, at the Boston Convention and Exhibition Center.
WALTHAM, Mass., Aug. 23, 2022 – Thermedical®, a developer of thermal-ablation systems to treat ventricular arrhythmias, announced today that the U.S. Food & Drug Administration (FDA) has approved an open-label, single-arm interventional clinical trial to evaluate the safety and efficacy of the Thermedical® SERF Ablation System with the Durablate® Catheter in people with ventricular tachycardia (VT) resistant to conventional treatment.
A research study of African Americans with cardiovascular disease suggests religious practices and spirituality may contribute to heart health.
Physician-scientists assessed whether lipid concentrations and rates of lipid control changed among U.S. adults from 2007 to 2018. The researchers observed that while mean cholesterol concentrations improved among U.S. adults overall during this time period, there were concerning variations in these trends by race and ethnicity.
By estimating people’s brain age from MRI scans using machine learning, a team led by UCL researchers has identified multiple risk factors for a prematurely ageing brain.
Research presented at ESC Congress 2022 supports a causal relationship between air pollution and heart attacks since smokers, who already inhale smoke, were unaffected by dirty air.1
About 78% of respondents who said they planned to get pregnant within the next five years expressed openness to wearing the monitor on a daily basis.
Researchers in the Smidt Heart Institute at Cedars-Sinai are one step closer to identifying patients at highest risk for developing sudden cardiac death—an electrical malfunction in the heart that causes it to stop beating.
A case-series study has found that adenoviral-based vaccines may be associated with increased risk for myocardial infarction (MI) and pulmonary embolism (PE). No association between mRNA vaccines and severe cardiovascular incidence was found in the short term. Myocarditis and pericarditis were not included in the study. Risk for The findings are published in Annals of Internal Medicine.
A case-control study has found that higher folate levels before or during early pregnancy are associated with a lower risk for congenital heart disease (CHD) in children. Folate supplementation may help, and levels of red blood cell (RBC) folate higher than those currently recommended may be warranted. The findings are published in Annals of Internal Medicine.
The latest research and expert commentary on the monkeypox outbreak.
Twenty-six Children's Hospital Los Angeles physicians, nurses and leaders will serve as presenters at the 25th Annual Cardiology 2022 Conference, themed “The New Normal: Transformation in Pediatric & Congenital Heart Disease.”
In a detailed analysis of nearly 43 million people, ages 13 and older, who received at least one dose of a COVID-19 vaccine in England, the risk of myocarditis in unvaccinated individuals after COVID-19 infection was at least 11 times higher compared to people who developed myocarditis after receiving a COVID-19 vaccine or booster dose between December 1, 2020 and December 15, 2021, according to new research published today in the American Heart Association’s flagship, peer-reviewed journal Circulation.
Experts from the Smidt Heart Institute at Cedars-Sinai, home to California’s top-ranked cardiology and heart surgery programs, will present an array of innovative research—including late-breaking science—during the European Society of Cardiology Congress 2022, taking place in person and virtually Aug. 26-29.
Cannabis prescribed for chronic pain is associated with an elevated risk of heart rhythm disorders, according to research presented at ESC Congress 2022.
COVID mRNA vaccines are associated with a decreased risk of death in patients with heart failure, according to research presented at ESC Congress 2022.
قد يبدو أن فشل القلب من أمراض التقدم في العمر، إلا إنه يمكن أن يصيب المرء في أي وقت خلال حياته. وفي كثير من الحالات، يمكن الوقاية منه أو علاجه. في هذا المقال تشرح قوسية وامل، دكتور الطب، الحاصلة على الدكتوراه، طبيبة القلب في مايو كلينك للرعاية الصحية في لندن، عوامل الخطر، والأعراض التي قد يجهلها الناس وكيفية علاج فشل القلب.
A insuficiência cardíaca pode parecer uma doença de pessoas em idade avançada, mas ela pode se desenvolver em qualquer momento da vida. E, em muitos casos, ela pode ser prevenida ou tratada.
心力衰竭可能看上去是一种老年病，但它在任何年龄段都可能发生。在很多情况下，这种疾病是可以预防或治疗的。在本次专家提醒中，伦敦Mayo Clinic Healthcare的心脏病专家Gosia Wamil（医学博士、哲学博士）讲述了人们可能没有注意到的心力衰竭风险因素、症状，以及治疗方法。
Aunque aparentemente la insuficiencia cardíaca sea una enfermedad que se presenta a una edad avanzada, puede desarrollarse a cualquier edad; y en muchos casos, es posible prevenirla y tratarla.
A review of the latest research highlights the most reported symptoms of various cardiovascular diseases (CVDs), noting that men and women often experience different symptoms, according to a new American Heart Association scientific statement published today in the Association’s flagship peer-reviewed journal, Circulation.
Patients with prior COVID may be twice as likely to have unhealthy endothelial cells that line the inside of the heart and blood vessels, according to newly published research from Houston Methodist. This finding offers a new clue in understanding COVID-19’s impact on cardiovascular health.
Motion analysis of video recorded on a smartphone accurately detected narrowed arteries in the neck, which are a risk factor for stroke, according to new research published today in the Journal of the American Heart Association, an open access, peer-reviewed journal of the American Heart Association.
Hospital is one of only five in the U.S. selected to participate in early clinical trial for the minimally invasive Impella BTR technology
Five Hackensack Meridian Health medical centers have received the American College of Cardiology’s NCDR Chest Pain ̶ MI Registry Platinum Performance Achievement Award for 2022. These medical centers join only 240 hospitals nationwide to receive the honor.
Pascack Valley Medical Group announced that Mohammed Gibreal, M.D. has joined the practice’s cardiology group. As a noninvasive cardiologist practicing in community hospitals and tertiary care medical centers, Dr. Gibreal has vast experience delivering care in inpatient and outpatient settings.
A decision model found that the relative clinical benefit of left atrial appendage occlusion (LAAO) and oral anticoagulants (OAC) in patients with atrial fibrillation depends on the patients' baseline risks for stroke and bleeding. LAAOs were found to be the preferred strategy in those with the highest bleeding risk. This benefit became less certain with increasing risk for ischemic stroke and decreasing bleeding risk. The findings are published in Annals of Internal Medicine.
Why does the risk of heart disease go up as we age? Known risk factors such as hypertension or high cholesterol don’t explain all cases.
Seven Hackensack Meridian Health medical centers have received American Heart Association Get With The Guidelines® - Heart Failure Quality Achievement Awards. The awards recognize the medical centers’ commitment to improving outcomes for patients with heart failure, reducing patient readmissions and providing more healthy days at home.
Two leaders in cardiovascular disease science, research and education, the American Heart Association (Association) and the Cardiovascular Research Foundation (CRF), are joining forces to strengthen and expand educational opportunities focused on advancing the latest research in cardiovascular disease and interventional therapies. The new alliance to produce joint education programs begins immediately with the organizations’ annual scientific meetings this fall. The Association will present educational programming from its annual Scientific Sessions at TCT, and CRF will deliver educational programming from its annual scientific symposium Transcatheter Cardiovascular Therapeutics (TCT) at the Association’s Scientific Sessions, beginning with TCT 2022, September 16-19 in Boston, and the Association’s Scientific Sessions 2022, November 5-7 in Chicago, respectively.
Researchers in the Biomedical Engineering Department at UConn have developed a new cardiac cell-derived platform that closely mimics the human heart, unlocking potential for more thorough preclinical drug development and testing, and model for cardiac diseases.
Researchers at Ochsner Health and Tulane University School of Medicine have identified the genes that become active in carotid arteries when plaque rupture causes a stroke. The work, published in Scientific Reports, was made possible by acquiring samples closer to the time of the stroke than previously possible. The results provide a picture of what the cells in the plaque are doing near the moment they induce a stroke.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
